A. Boots (Maastricht, Netherlands), S. Rolandsson Enes (Lund, Sweden)
Introduction
A. Boots (Maastricht, Netherlands), S. Rolandsson Enes (Lund, Sweden)
|  |
Extracellular vesicles propagate cellular senescence by transferring miR34a in airway epithelial cells
J. Devulder (London, United Kingdom), J. Baker (London, United Kingdom), L. Odqvist (Gothenburg, Sweden), L. Donnelly (London, United Kingdom), P. Barnes (London, United Kingdom)
|    |
SFRP1-linked to extracellular vesicles promotes pulmonary fibrosis
O. Burgy (Dijon, France), C. Mayr (Munich, Germany), B. Ballester Llobell (Munich, Germany), A. Sengupta (Munich, Germany), S. Loriod (Dijon, France), A. Yildirim (Munich, Germany), M. Lehmann (Munich, Germany), H. Schiller (Munich, Germany), G. Burgstaller (Munich, Germany), M. Königshoff (Pittsburgh, United States)
| |
Potential prothrombotic role of extracellular vesicles during exacerbation of chronic obstructive pulmonary disease
T. Neri (Pisa (PI), Italy), D. Nieri (Pisa (PI), Italy), F. Ceriegi (Pisa (PI), Italy), C. Morani (Pisa (PI), Italy), E. Bazzan (Padova (PD), Italy), A. Celi (Pisa (PI), Italy)
| |
MSC extracellular vesicles ameliorate ARDS via activation of mitochondrial biogenesis
C. McClintock (Belfast, United Kingdom), J. Silva (Belfast, United Kingdom), D. Doherty (Belfast, United Kingdom), C. O'Kane (Belfast, United Kingdom), D. Mc Auley (Belfast, United Kingdom), A. Krasnodembskaya (Belfast, United Kingdom)
| |
Characterization of Mesenchymal Cell from BAL of post COVID-19 patient whit fibrosis
M. Della Zoppa (Pavia, Italy), M. Avanzini (Pavia, Italy), S. Bozzini (Pavia, Italy), S. Croce (Pavia, Italy), C. Bagnera (Pavia, Italy), C. Valsecchi (Pavia, Italy), L. Pandolfi (Pavia, Italy), E. Lenta (Pavia, Italy), S. Lettieri (Pavia, Italy), V. Vertui (Pavia, Italy), L. Saracino (Pavia, Italy), F. Meloni (Pavia, Italy)
| |
Mitochondrial dysfunction features in lung resident mesenchymal stem cells from patients with Idiopathic Pulmonary Fibrosis
A. Martín Medina (Palma, Spain), J. Truyols-Vives (Palma, Spain), L. Elowson (Lund, Sweden), A. Jahn (Palma, Spain), C. Rio (Palma, Spain), A. Iglesias (Palma, Spain), A. Montes (Barcelona, Spain), J. Velasco (Palma, Spain), M. Molina-Molina (Barcelona, Spain), G. Westergren-Thorsson (Lund, Sweden), J. Mercader-Barceló (Palma, Spain), E. Sala-Llinas (Palma, Spain)
| |
LSC - 2022 - Biomarker identification to assess effects of bone-marrow derived mesenchymal stromal cell-therapy in emphysema through immune profiling
P. Khedoe (Leiden, Netherlands), L. Jia (Leiden, Netherlands), N. Li (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands), F. Koning (Leiden, Netherlands), J. Stolk (Leiden, Netherlands)
| |
Mesenchymal Stem Cells derived Biospheres (BS) as potential therapeutic agent in lung disease like Idiopathic Pulmonary Fibrosis (IPF)
A. Jahn (Palma de Mallorca, Spain), C. Rio (Palma de Mallorca, Spain), A. Martin-Medina (Palma de Mallorca, Spain), A. Iglesias (Palma de Mallorca, Spain), J. Pierola (Palma de Mallorca, Spain), O. Traore Diaby (Palma de Mallorca, Spain), E. Sala Llinas (Palma de Mallorca, Spain)
| |
Combined Cell Therapy and Anticoagulants as a treatment for an in vivo model of Acute Lung Injury
M. Camprubí-Rimblas (Sabadell, Spain), A. Areny-Balagueró (Sabadell, Spain), E. Campaña-Duel (Sabadell, Spain), L. Morales-Quinteros (Barcelona, Spain), A. Ceccato (Sabadell, Spain), L. Blanch (Sabadell, Spain), A. Artigas (Sabadell, Spain)
| |
Late Breaking Abstract - Human induced pluripotent stem cell-derived alveolar type 2 cells mature at air-liquid interface and respond to airborne stimuli
K. Abo (Boston, United States), A. Wilson (Boston, United States)
| |